Nice : the Kyrn laboratory raises 12.5 million francs

The Kyrn laboratory from Nice (skin care product) has raised 12.5 million francs with Turenne Capital, an innovation mutual-fund for the launching of its main product Keotyl. The company from Nice, which was helped by the ANVAR, had already succeed a first investment last year for the launching of this product (2.5 million francs with Sofipaca). The keotyl, which cures first and second degree burnings, is today on the market. The money invested will be used for the marketing of Keotyl in Europe.